Insider Transactions in Q2 2024 at Steris PLC (STE)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 05
2024
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Open market or private sale
|
Direct |
3,652
-14.57%
|
$839,960
$230.0 P/Share
|
|
Jun 05
2024
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
3,652
+11.96%
|
$266,596
$73.4 P/Share
|
|
Jun 05
2024
|
Cary L Majors SVP and President, Healthcare |
SELL
Open market or private sale
|
Direct |
4,932
-27.42%
|
$1,129,428
$229.63 P/Share
|
|
Jun 05
2024
|
Cary L Majors SVP and President, Healthcare |
BUY
Exercise of conversion of derivative security
|
Direct |
4,932
+21.52%
|
$562,248
$114.22 P/Share
|
|
Jun 04
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,423
+7.38%
|
-
|
|
Jun 04
2024
|
Renato Tamaro V.P. & Corporate Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
663
+8.79%
|
-
|
|
Jun 04
2024
|
Kenneth E Kohler SVP & GM, AST |
BUY
Grant, award, or other acquisition
|
Direct |
1,539
+30.65%
|
-
|
|
Jun 04
2024
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
4,128
+11.02%
|
-
|
|
Jun 04
2024
|
Cary L Majors SVP and President, Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
2,379
+15.42%
|
-
|
|
Jun 04
2024
|
Mary Clare Fraser SVP & Chief HRO |
BUY
Grant, award, or other acquisition
|
Direct |
2,040
+15.49%
|
-
|
|
Jun 04
2024
|
Karen L Burton VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
918
+17.3%
|
-
|
|
Jun 04
2024
|
Daniel A Carestio President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,849
+18.58%
|
-
|
|
Jun 04
2024
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
1,626
+14.39%
|
-
|
|
Jun 04
2024
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,063
-2.39%
|
$242,364
$228.37 P/Share
|
|
Jun 03
2024
|
Mary Clare Fraser SVP & Chief HRO |
SELL
Payment of exercise price or tax liability
|
Direct |
236
-2.53%
|
$53,808
$228.37 P/Share
|
|
Jun 03
2024
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
389
-2.0%
|
$88,692
$228.37 P/Share
|
|
Jun 03
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,377
-1.93%
|
$541,956
$228.37 P/Share
|
|
Jun 03
2024
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
723
-0.81%
|
$164,844
$228.37 P/Share
|
|
Jun 03
2024
|
Cary L Majors SVP and President, Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
694
-6.1%
|
$158,232
$228.37 P/Share
|
|
Jun 03
2024
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
187
-1.73%
|
$42,636
$228.37 P/Share
|
|
Jun 03
2024
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,160
-1.28%
|
$264,480
$228.37 P/Share
|
|
Jun 03
2024
|
Kenneth E Kohler SVP & GM, AST |
SELL
Payment of exercise price or tax liability
|
Direct |
154
-2.51%
|
$35,112
$228.37 P/Share
|
|
Jun 03
2024
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
299
-1.21%
|
$68,172
$228.37 P/Share
|
|
May 31
2024
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-1.14%
|
$76,812
$222.88 P/Share
|
|
May 31
2024
|
Kenneth E Kohler SVP & GM, AST |
SELL
Payment of exercise price or tax liability
|
Direct |
112
-5.07%
|
$24,864
$222.88 P/Share
|
|
May 31
2024
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
207
-2.42%
|
$45,954
$222.88 P/Share
|
|
May 31
2024
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
72
-1.08%
|
$15,984
$222.88 P/Share
|
|
May 31
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
580
-1.37%
|
$128,760
$222.88 P/Share
|
|
May 31
2024
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
124
-1.92%
|
$27,528
$222.88 P/Share
|
|
May 31
2024
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,286
-2.74%
|
$285,492
$222.88 P/Share
|
|
May 31
2024
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
102
-2.71%
|
$22,644
$222.88 P/Share
|
|
May 21
2024
|
Richard C Breeden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,584
+12.34%
|
$233,784
$51.53 P/Share
|
|
May 16
2024
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Open market or private sale
|
Direct |
1,154
-14.74%
|
$266,574
$231.64 P/Share
|
|
May 16
2024
|
Renato Tamaro V.P. & Corporate Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,154
+12.84%
|
$131,556
$114.22 P/Share
|
|
May 15
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
32,000
-12.66%
|
$7,488,000
$234.98 P/Share
|
|
May 15
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
32,000
+30.06%
|
$2,464,000
$77.07 P/Share
|
|
May 15
2024
|
Cynthia L Feldmann Director |
SELL
Open market or private sale
|
Direct |
2,000
-73.94%
|
$474,000
$237.65 P/Share
|
|
May 15
2024
|
Cynthia L Feldmann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+42.51%
|
$172,000
$86.23 P/Share
|
|
May 14
2024
|
Karen L Burton VP & CAO |
SELL
Open market or private sale
|
Direct |
3,000
-44.39%
|
$705,000
$235.95 P/Share
|
|
May 14
2024
|
Mohsen Sohi Director |
SELL
Open market or private sale
|
Direct |
2,037
-4.25%
|
$474,621
$233.5 P/Share
|
|
May 14
2024
|
Mohsen Sohi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,037
+7.71%
|
$103,887
$51.53 P/Share
|
|
May 13
2024
|
Cary L Majors SVP and President, Healthcare |
SELL
Open market or private sale
|
Direct |
2,024
-15.11%
|
$469,568
$232.13 P/Share
|
|
May 13
2024
|
Jacqueline B Kosecoff Director |
SELL
Open market or private sale
|
Direct |
4,584
-100.0%
|
$1,058,904
$231.53 P/Share
|
|
May 13
2024
|
Jacqueline B Kosecoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,584
+50.0%
|
$233,784
$51.53 P/Share
|